241 related articles for article (PubMed ID: 20980052)
1. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations.
Kajiya H; Okamoto F; Nemoto T; Kimachi K; Toh-Goto K; Nakayana S; Okabe K
Cell Calcium; 2010 Nov; 48(5):260-9. PubMed ID: 20980052
[TBL] [Abstract][Full Text] [Related]
2. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.
Hwang SY; Putney JW
FASEB J; 2012 Apr; 26(4):1484-92. PubMed ID: 22198385
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
4. Calcium signaling in osteoclast differentiation and bone resorption.
Kajiya H
Adv Exp Med Biol; 2012; 740():917-32. PubMed ID: 22453976
[TBL] [Abstract][Full Text] [Related]
5. TRPV2-induced Ca
Bai H; Zhu H; Yan Q; Shen X; Lu X; Wang J; Li J; Chen L
Cell Commun Signal; 2018 Oct; 16(1):68. PubMed ID: 30326911
[TBL] [Abstract][Full Text] [Related]
6. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
7. Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.
Yang YM; Kim MS; Son A; Hong JH; Kim KH; Seo JT; Lee SI; Shin DM
J Bone Miner Res; 2009 Oct; 24(10):1763-9. PubMed ID: 19419309
[TBL] [Abstract][Full Text] [Related]
8. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis.
Kim MS; Yang YM; Son A; Tian YS; Lee SI; Kang SW; Muallem S; Shin DM
J Biol Chem; 2010 Mar; 285(10):6913-21. PubMed ID: 20048168
[TBL] [Abstract][Full Text] [Related]
9. RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.
Yang S; Li YP
J Bone Miner Res; 2007 Jan; 22(1):45-54. PubMed ID: 17042716
[TBL] [Abstract][Full Text] [Related]
10. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
12. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
Son A; Kang N; Oh SY; Kim KW; Muallem S; Yang YM; Shin DM
J Endocrinol; 2019 Sep; 242(3):241-249. PubMed ID: 31319381
[TBL] [Abstract][Full Text] [Related]
13. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein.
Hada N; Okayasu M; Ito J; Nakayachi M; Hayashida C; Kaneda T; Uchida N; Muramatsu T; Koike C; Masuhara M; Sato T; Hakeda Y
Bone; 2012 Jan; 50(1):226-36. PubMed ID: 22075210
[TBL] [Abstract][Full Text] [Related]
15. Pulsed electromagnetic field inhibits RANKL-dependent osteoclastic differentiation in RAW264.7 cells through the Ca
Zhang J; Xu H; Han Z; Chen P; Yu Q; Lei Y; Li Z; Zhao M; Tian J
Biochem Biophys Res Commun; 2017 Jan; 482(2):289-295. PubMed ID: 27856256
[TBL] [Abstract][Full Text] [Related]
16. Glechoma hederacea Suppresses RANKL-mediated Osteoclastogenesis.
Hwang JK; Erkhembaatar M; Gu DR; Lee SH; Lee CH; Shin DM; Lee YR; Kim MS
J Dent Res; 2014 Jul; 93(7):685-90. PubMed ID: 24850617
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
18. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis.
Li CH; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Liu XY
Biochem Biophys Res Commun; 2013 Jun; 435(4):533-9. PubMed ID: 23665018
[TBL] [Abstract][Full Text] [Related]
19. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
Chen F; Ouyang Y; Ye T; Ni B; Chen A
J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
